Transition period of estrogen-progestogen hormone therapy
نویسندگان
چکیده
منابع مشابه
Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy.
Working Group Members1 Garnet L. Anderson, Women’s Health Initiative, Clinical Coordinating Center, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N, M3-A410, PO Box 19024, Seattle, WA 98109, USA Philippe Autier, Unit of Epidemiology, Prevention and Screening, Jules Bordet Institute, Boulevard de Waterloo 125, Brussels 1000, Belgium Valerie Beral, Cancer Epidemiology Unit, Univers...
متن کاملIschemic stroke and use of estrogen and estrogen/progestogen as hormone replacement therapy.
BACKGROUND AND PURPOSE Information about the risk of stroke in current postmenopausal hormone users is limited. METHODS In this case-control study, women aged 45 to 74 years hospitalized with a fatal or nonfatal stroke in any of 10 Northern California Kaiser Permanente facilities during the period November 1991 to November 1994 were identified as cases. Controls were selected at random from f...
متن کاملCombined Estrogen–progestogen Contraceptives
Combined hormonal contraceptives consist of an estrogen and a progestogen, and act primarily by preventing ovulation through the inhibition of the follicle-stimulating hormone and luteinizing hormone. The progestogen component also renders the cervical mucus relatively impenetrable to sperm, and reduces the receptivity of the endometrium to implantation (IARC, 2007). A variety of innovations ha...
متن کاملCombined Estrogen–progestogen Contraceptives
Combined hormonal contraceptives consist of an estrogen and a progestogen, and act primarily by preventing ovulation through the inhibition of follicle-stimulating hormone and luteinizing hormone. The progestogen component also renders the cervical mucus relatively impenetrable to sperm and reduces the receptivity of the endometrium to implantation. These mechanisms render combined hormonal con...
متن کاملCombined Estrogen–progestogen Contraceptives
Combined hormonal contraceptives consist of an estrogen and a progestogen, and act primarily by preventing ovulation through the inhibition of the follicle-stimulating hormone and luteinizing hormone. The progestogen component also renders the cervical mucus relatively impenetrable to sperm, and reduces the receptivity of the endometrium to implantation (IARC, 2007). A variety of innovations ha...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Medical alphabet
سال: 2019
ISSN: 2078-5631
DOI: 10.33667/2078-5631-2019-3-25(400)-6-10